Big Pharma giant Pfizer confirmed on Wednesday that it will settle more than 10,000 lawsuits over allegations that the company

Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.

Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the litigation.

The Pfizer settlements come as GSK, a previous Zantac manufacturer, defends itself in an ongoing trial, while Sanofi, which recalled the drug in 2019 over cancer claims, agreed to pay more than $100 million to resolve its Zantac cases.

Financial terms of the settlements were not immediately disclosed for the discontinued over-the-counter drug that was used to treat heartburn

P fizer has reportedly agreed to settle more than 10,000 lawsuits that were filed over alleged cancer risks related to the discontinued heartburn drug Zantac. The company has been accused of failing to warn people about a cancer-causing substance called NDMA that was found in the drug.